Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 91 Neoplasm Metastasis 24 Neoplasms 14 Brain Neoplasms 13 Prostatic Neoplasms 10 Endometrial Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Ovarian Neoplasms 7 Glioblastoma 7 Glioma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Sarcoma 4 Recurrence 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Sarcoma, Ewing 3 Osteosarcoma 3 Neoplasms by Site 3 Multiple Myeloma 3 Meningioma 3 Melanoma 3 Carcinoma, Renal Cell 3 Breast Diseases 3 Unilateral Breast Neoplasms 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Oligodendroglioma 2

Interventions

Fulvestrant 6 Letrozole 4 exemestane 3 dalpiciclib 3 Trastuzumab 3 Docetaxel 3 Capecitabine 3 Anastrozole 3 ribociclib 2 palbociclib 2 fluzoparib 2 apatinib 2 Irinotecan 2 Gemcitabine 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 sacituzumab govitecan 1 pyrotinib 1 pegfilgrastim 1 patritumab deruxtecan 1 olaparib 1 nirogacestat 1 margetuximab 1 irinotecan sucrosofate 1 abemaciclib 1 Zoledronic Acid 1 Vinorelbine 1 Tamoxifen 1 Rogaratinib 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Metastatic × abemaciclib × Clear all

NCT04603183 2025-12-12

ABIGAIL

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡